Clinical Trial Update: TKI258 in Castrate Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TKI258 in castration-resistant prostate cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TKI258

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-09-11